Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Profit After Tax (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Profit After Tax data on record, last reported at $5.8 million in Q3 2025.

  • For Q3 2025, Profit After Tax rose 121.92% year-over-year to $5.8 million; the TTM value through Sep 2025 reached -$33.4 million, up 81.37%, while the annual FY2024 figure was -$120.9 million, 21.6% up from the prior year.
  • Profit After Tax reached $5.8 million in Q3 2025 per FBIO's latest filing, down from $15.5 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $31.6 million in Q4 2021 and bottomed at -$102.8 million in Q4 2023.
  • Average Profit After Tax over 5 years is -$21.9 million, with a median of -$21.5 million recorded in 2023.
  • Peak YoY movement for Profit After Tax: soared 254.29% in 2021, then crashed 2923.29% in 2023.
  • A 5-year view of Profit After Tax shows it stood at $31.6 million in 2021, then plummeted by 88.48% to $3.6 million in 2022, then plummeted by 2923.29% to -$102.8 million in 2023, then skyrocketed by 57.01% to -$44.2 million in 2024, then soared by 113.24% to $5.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Profit After Tax were $5.8 million in Q3 2025, $15.5 million in Q2 2025, and -$10.6 million in Q1 2025.